相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Interaction between DNA, Albumin and Apo-Transferrin and Iridium(III) Complexes with Phosphines Derived from Fluoroquinolones as a Potent Anticancer Drug
Sandra Amanda Koziel et al.
PHARMACEUTICALS (2021)
Easily Available, Amphiphilic Diiron Cyclopentadienyl Complexes Exhibit in Vitro Anticancer Activity in 2D and 3D Human Cancer Cells through Redox Modulation Triggered by CO Release
Lorenzo Biancalana et al.
CHEMISTRY-A EUROPEAN JOURNAL (2021)
Phosphorescent metal complexes as theranostic anticancer agents: combining imaging and therapy in a single molecule
Cai-Ping Tan et al.
CHEMICAL SCIENCE (2021)
Anticancer potency of novel organometallic Ir(iii) complexes with phosphine derivatives of fluoroquinolones encapsulated in polymeric micelles
Sandra Koziel et al.
INORGANIC CHEMISTRY FRONTIERS (2020)
Anticancer activity of ruthenium and osmium cyclometalated compounds: identification of ABCB1 and EGFR as resistance mechanisms
Cynthia Licona et al.
INORGANIC CHEMISTRY FRONTIERS (2020)
Anticancer Cyclometalated Iridium(III) Complexes with Planar Ligands: Mitochondria! DNA Damage and Metabolism Disturbance
Jian-Jun Cao et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Reactive Oxygen Species (ROS)-Based Nanomedicine
Bowen Yang et al.
CHEMICAL REVIEWS (2019)
Studies of anticancer activity in vitro and in vivo of iridium(III) polypyridyl complexes-loaded liposomes as drug delivery system
Wen-Yao Zhang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Triple negative breast cancer and platinum-based systemic treatment: a meta-analysis and systematic review
Jessa Gilda P. Pandy et al.
BMC CANCER (2019)
Potential anticancer agent for selective damage to mitochondria or lysosomes: Naphthalimide-modified fluorescent biomarker half-sandwich iridium (III) and ruthenium (II) complexes
Wenli Ma et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Assembly of Fully Substituted 2H-Indazoles Catalyzed by Cu2O Rhombic Dodecahedra and Evaluation of Anticancer Activity
Rajeeva Lochana Panchangam et al.
CHEMMEDCHEM (2019)
Clinicopathological factors associated with novel prognostic markers for patients with triple negative breast cancer
Anna M. Badowska-Kozakiewicz et al.
ARCHIVES OF MEDICAL SCIENCE (2019)
Analysis of the Mitochondrial Membrane Potential Using the Cationic JC-1 Dye as a Sensitive Fluorescent Probe
Farzane Sivandzade et al.
BIO-PROTOCOL (2019)
Selective Inhibition of Lysine-Specific Demethylase 5A (KDM5A) Using a Rhodium(III) Complex for Triple-Negative Breast Cancer Therapy
Guan-Jun Yang et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2018)
Triple negative breast cancer: Emerging therapeutic modalities and novel combination therapies
Alice Lee et al.
CANCER TREATMENT REVIEWS (2018)
The side effects of platinum-based chemotherapy drugs: a review for chemists
Rabbab Oun et al.
DALTON TRANSACTIONS (2018)
An iridium (III) complex as potent anticancer agent induces apoptosis and autophagy in B16 cells through inhibition of the AKT/mTOR pathway
Bing Tang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Ru(II) Compounds: Next-Generation Anticancer Metallotherapeutics?
Sreekanth Thota et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Pharmaco-genomic investigations of organo-iridium anticancer complexes reveal novel mechanism of action
Jessica M. Hearn et al.
METALLOMICS (2018)
Triple action Pt(IV) derivatives of cisplatin: a new class of potent anticancer agents that overcome resistance
Emanuele Petruzzella et al.
CHEMICAL SCIENCE (2018)
Iridium (III) complex-loaded liposomes as a drug delivery system for lung cancer through mitochondrial dysfunction
Cancheng Liao et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2018)
Half-Sandwich Iridium and Ruthenium Complexes: Effective Tracking in Cells and Anticancer Studies
JuanJuan Li et al.
INORGANIC CHEMISTRY (2018)
Mitochondrial metabolism and cancer
Paolo Ettore Porporato et al.
CELL RESEARCH (2018)
Dual-functional cyclometalated iridium imine NHC complexes: highly potent anticancer and antimetastatic agents
Zhenzhen Tian et al.
INORGANIC CHEMISTRY FRONTIERS (2018)
Cyclometalated iridium(III)-guanidinium complexes as mitochondria-targeted anticancer agents
Xing-Dong Song et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Indazole-Based Covalent Inhibitors To Target Drug-Resistant Epidermal Growth Factor Receptor
Stefano Tomassi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Dual Functions of Cyclometalated Iridium(III) Complexes: Anti-Metastasis and Lysosome-Damaged Photodynamic Therapy
Fang-Xin Wang et al.
ACS APPLIED MATERIALS & INTERFACES (2017)
Inhibition of PI3K/Akt/mTOR overcomes cisplatin resistance in the triple negative breast cancer cell line HCC38
Katharina Gohr et al.
BMC CANCER (2017)
Endoplasmic Reticulum-Localized Iridium(III) Complexes as Efficient Photodynamic Therapy Agents via Protein Modifications
Jung Seung Nam et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2016)
Interstitial Release of Cisplatin from Triggerable Liposomes Enhances Efficacy against Triple Negative Breast Cancer Solid Tumor Analogues
Sally Stras et al.
MOLECULAR PHARMACEUTICS (2016)
Pt(IV) derivatives of cisplatin and oxaliplatin with phenylbutyrate axial ligands are potent cytotoxic agents that act by several mechanisms of action
Raji Raveendran et al.
CHEMICAL SCIENCE (2016)
Ester-Modified Cyclometalated Iridium(III) Complexes as Mitochondria-Targeting Anticancer Agents
Fang-Xin Wang et al.
SCIENTIFIC REPORTS (2016)
Modulating the Anticancer Activity of Ruthenium(II)-Arene Complexes
Catherine M. Clavel et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Lipid Nanocarriers of a Lipid-Conjugated Estrogenic Derivative Inhibit Tumor Growth and Enhance Cisplatin Activity against Triple-Negative Breast Cancer: Pharmacokinetic and Efficacy Evaluation
Terrick Andey et al.
MOLECULAR PHARMACEUTICS (2015)
CFAssay: statistical analysis of the colony formation assay
Herbert Braselmann et al.
RADIATION ONCOLOGY (2015)
Organoiridium Complexes: Anticancer Agents and Catalysts
Zhe Liu et al.
ACCOUNTS OF CHEMICAL RESEARCH (2014)
Theranostic Iridium(III) Complexes as One- and Two-Photon Phosphorescent Trackers to Monitor Autophagic Lysosomes
Liang He et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2014)
On the antitumor properties of novel cyclometalated benzimidazole Ru(II), Ir(III) and Rh(III) complexes
Gorakh S. Yellol et al.
CHEMICAL COMMUNICATIONS (2013)
Membrane Localized Iridium(III) Complex Induces Endoplasmic Reticulum Stress and Mitochondria-Mediated Apoptosis in Human Cancer Cells
Rui Cao et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Mitochondria in Apoptosis: Bcl-2 Family Members and Mitochondrial Dynamics
Jean-Claude Martinou et al.
DEVELOPMENTAL CELL (2011)
Iridium Complex with Antiangiogenic Properties
Alexander Wilbuer et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2010)
Reactive oxygen species, cellular redox systems, and apoptosis
Magdalena L. Circu et al.
FREE RADICAL BIOLOGY AND MEDICINE (2010)
Executioner caspase-3 and caspase-7 are functionally distinct proteases
John G. Walsh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The resurgence of platinum-based cancer chemotherapy
Lloyd Kelland
NATURE REVIEWS CANCER (2007)
Indazole estrogens:: Highly selective ligands for the estrogen receptor β
M De Angelis et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Caspase activation, inhibition, and reactivation: A mechanistic view
YG Shi
PROTEIN SCIENCE (2004)
A phase I and pharmacological study with imidazolium-trans-DMSO-imidazole-tetrachlororuthenate, a novel ruthenium anticancer agent
JM Rademaker-Lakhai et al.
CLINICAL CANCER RESEARCH (2004)
分享论文
